H.R.2577: To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.

About This Bill

  • This bill was introduced in the 108th Congress
  • This bill is primarily about congress
  • Introduced June 24, 2003
  • Latest Major Action July 2, 2003

Bill Summary

Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such...

(Source: Library of Congress)

Bill Actions

Date Description
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to House Energy and Commerce
Referred to House Ways and Means
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Trade.
June 24, 2003

Introduced in the House by Michael C. Burgess (R-Texas)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page